-
-
-
-
-
-
-
Ardelyx (ARDX) Kept at Neutral by Cantor Fitzgerald, "Need More Commercial Visibility"
-
-
-
-
-
-
-
Ardelyx Stock Trading Halted Today; FDA Advisory Committee to Discuss XPHOZAH® (tenapanor) for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis
-
-
-
-
-
-
-
Ardelyx Reports First Quarter 2022 Financial Results and Recent Business Highlights
-
-
-
-
13,403 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All